BACKGROUND: The NHLBI-sponsored Sickle Cell Disease Clinical Research Network (SCDCRN) conducted a multi-center, acute intervention randomized clinical trial of two methods of Patient Controlled Analgesia for acute pain. This trial was terminated early due to low enrollment. We analyzed the perceived barriers and recruitment difficulties as reported by the coordinators and principal investigators. METHODS:Participating sites completed a missed eligibility log of subjects admitted in pain crisis throughout the study and a survey at the end of the trial. The survey covered site-specific factors, policies, and procedures in study implementation, recruitment strategies, and eligibility factors. The New England Research Institutes (NERI) collected de-identified surveys from 31 respondents at 29 of 31 participating sites. RESULTS:From December 2009 to June 2010, 1116 patient encounters for SCD and pain occurred at participating institutions: 38 subjects were enrolled (14 pediatric and 24 adults) and 34 completed the trial, below the projected 278 subjects. Fourteen sites enrolled subjects and seventeen did not. Recruitment barriers included insufficient staff, subject ineligibility or in too much pain to consent, competing protocols, and concerns regarding pain control. Recruitment methods were referrals from urgent care, SCD clinics and in house databases. No use of media or outside physicians was reported. CONCLUSION: We identified multiple barriers to patient accrual including short duration of enrollment period, protocol design, complex dosing schedule, requirement for staff availability during week-end and after hours, multiple departments' involvement, protocol acceptance, eligibility criteria, competing protocols, and limited staff. Each of these areas should be targeted for intervention in order to plan and conduct successful future clinical trials. Published by Elsevier Inc.
RCT Entities:
BACKGROUND: The NHLBI-sponsored Sickle Cell Disease Clinical Research Network (SCDCRN) conducted a multi-center, acute intervention randomized clinical trial of two methods of Patient Controlled Analgesia for acute pain. This trial was terminated early due to low enrollment. We analyzed the perceived barriers and recruitment difficulties as reported by the coordinators and principal investigators. METHODS: Participating sites completed a missed eligibility log of subjects admitted in pain crisis throughout the study and a survey at the end of the trial. The survey covered site-specific factors, policies, and procedures in study implementation, recruitment strategies, and eligibility factors. The New England Research Institutes (NERI) collected de-identified surveys from 31 respondents at 29 of 31 participating sites. RESULTS: From December 2009 to June 2010, 1116 patient encounters for SCD and pain occurred at participating institutions: 38 subjects were enrolled (14 pediatric and 24 adults) and 34 completed the trial, below the projected 278 subjects. Fourteen sites enrolled subjects and seventeen did not. Recruitment barriers included insufficient staff, subject ineligibility or in too much pain to consent, competing protocols, and concerns regarding pain control. Recruitment methods were referrals from urgent care, SCD clinics and in house databases. No use of media or outside physicians was reported. CONCLUSION: We identified multiple barriers to patient accrual including short duration of enrollment period, protocol design, complex dosing schedule, requirement for staff availability during week-end and after hours, multiple departments' involvement, protocol acceptance, eligibility criteria, competing protocols, and limited staff. Each of these areas should be targeted for intervention in order to plan and conduct successful future clinical trials. Published by Elsevier Inc.
Authors: Frinny R Polanco; Dinora C Dominguez; Christine Grady; Pamela Stoll; Catalina Ramos; Joann M Mican; Robert Miranda-Acevedo; Marcela Morgan; Jeasmine Aizvera; Lori Purdie; Deloris Koziol; Migdalia V Rivera-Goba Journal: J Assoc Nurses AIDS Care Date: 2011-02-01 Impact factor: 1.354
Authors: Denae W King; Theresa M Duello; Patricia Y Miranda; Kelly P Hodges; Andrea J Shelton; Paul Chukelu; Lovell A Jones Journal: J Womens Health (Larchmt) Date: 2010-05 Impact factor: 2.681
Authors: Mark T Gladwin; Gregory J Kato; Debra Weiner; Onyinye C Onyekwere; Carlton Dampier; Lewis Hsu; R Ward Hagar; Thomas Howard; Rachelle Nuss; Maureen M Okam; Carole K Tremonti; Brian Berman; Anthony Villella; Lakshmanan Krishnamurti; Sophie Lanzkron; Oswaldo Castro; Victor R Gordeuk; Wynona A Coles; Marlene Peters-Lawrence; James Nichols; Mary K Hall; Mariana Hildesheim; William C Blackwelder; James Baldassarre; James F Casella Journal: JAMA Date: 2011-03-02 Impact factor: 56.272
Authors: James F Casella; Allison A King; Bruce Barton; Desiree A White; Michael J Noetzel; Rebecca N Ichord; Cindy Terrill; Deborah Hirtz; Robert C McKinstry; John J Strouse; Thomas H Howard; Thomas D Coates; Caterina P Minniti; Andrew D Campbell; Bruce A Vendt; Harold Lehmann; Michael R Debaun Journal: Pediatr Hematol Oncol Date: 2010-03 Impact factor: 1.969
Authors: O S Platt; B D Thorington; D J Brambilla; P F Milner; W F Rosse; E Vichinsky; T R Kinney Journal: N Engl J Med Date: 1991-07-04 Impact factor: 91.245
Authors: Anneke T Schroen; Gina R Petroni; Hongkun Wang; Monika J Thielen; Daniel Sargent; Jacqueline K Benedetti; Walter M Cronin; Donald L Wickerham; Xiaofei F Wang; Robert Gray; Wendy F Cohn; Craig L Slingluff; Benjamin Djulbegovic Journal: Clin Trials Date: 2011-08-30 Impact factor: 2.486
Authors: Carol R Horowitz; Barbara L Brenner; Susanne Lachapelle; Duna A Amara; Guedy Arniella Journal: Am J Prev Med Date: 2009-12 Impact factor: 5.043
Authors: Sandra Crouse Quinn; James Butler; Craig S Fryer; Mary A Garza; Kevin H Kim; Christopher Ryan; Stephen B Thomas Journal: Contemp Clin Trials Date: 2012-07-05 Impact factor: 2.226
Authors: Oluwakemi Badaki-Makun; J Paul Scott; Julie A Panepinto; T Charles Casper; Cheryl A Hillery; J Michael Dean; David C Brousseau Journal: Pediatr Blood Cancer Date: 2014-01-17 Impact factor: 3.167
Authors: Jeffrey D Lebensburger; Robert F Sidonio; Michael R Debaun; Monika M Safford; Thomas H Howard; Isabel C Scarinci Journal: Pediatr Blood Cancer Date: 2013-02-15 Impact factor: 3.167
Authors: Winson Y Cheung; Lindsay A Renfro; David Kerr; Aimery de Gramont; Leonard B Saltz; Axel Grothey; Steven R Alberts; Thierry Andre; Katherine A Guthrie; Roberto Labianca; Guido Francini; Jean-Francois Seitz; Chris O'Callaghan; Chris Twelves; Eric Van Cutsem; Daniel G Haller; Greg Yothers; Daniel J Sargent Journal: J Clin Oncol Date: 2016-02-08 Impact factor: 44.544
Authors: Carlton D Dampier; Wally R Smith; Carrie G Wager; Hae-Young Kim; Margaret C Bell; Scott T Miller; Debra L Weiner; Caterina P Minniti; Lakshmanan Krishnamurti; Kenneth I Ataga; James R Eckman; Lewis L Hsu; Donna McClish; Sonja M McKinlay; Robert Molokie; Ifeyinwa Osunkwo; Kim Smith-Whitley; Marilyn J Telen Journal: Clin Trials Date: 2013-04 Impact factor: 2.486
Authors: Carlton D Dampier; Carrie G Wager; Ryan Harrison; Lewis L Hsu; Caterina P Minniti; Wally R Smith Journal: Am J Hematol Date: 2012-08-07 Impact factor: 10.047